A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

Phase 3 Terminated 46 enrolled Astellas Pharma Inc

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the efficacy of ASP1941 based on the changes in HbA1C as well as its safety in Asian subjects with type 2 diabetes mellitus.

Timeline

Start: 2012-04-23
Primary completion: 2012-10-19
Completion: 2012-10-19

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Acarbose	Unknown	—	Oral
Subject	ipragliflozin	Small molecule	—	Oral

A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

Summary

Timeline

Drugs

Indications